These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 6124435

  • 1. Lack of effect of des-tyrosine1-gamma-endorphin on in vivo [3H]spiperone binding.
    Lahti RA, Gay DD.
    Eur J Pharmacol; 1982 May 07; 80(1):127-9. PubMed ID: 6124435
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of in vivo 3H-spiperone binding by the proposed antipsychotic Des-Tyr1-gamma-endorphin.
    Pedigo NW, Schallert T, Overstreet DH, Ling NC, Ragan P, Reisine TD, Yamamura HI.
    Eur J Pharmacol; 1979 Dec 20; 60(4):359-64. PubMed ID: 43261
    [Abstract] [Full Text] [Related]

  • 3. Examination of des-tyrosine1-gamma-endorphin activity at oH-spiroperidol binding sites in rat brain.
    Pedigo NW, Ling NC, Reisine TD, Yamamura HI.
    Life Sci; 1979 Apr 30; 24(18):1645-9. PubMed ID: 481099
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vivo interaction of gamma-type endorphins with dopaminergic ligands in rat brain.
    Codd EE, Scholtens H, Wolterink G, Verhoef JC, Van Ree JM, Witter A.
    Eur J Pharmacol; 1983 Apr 08; 88(4):365-70. PubMed ID: 6861877
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dramatic increase in pineal melatonin levels in the rat after subcutaneous injection of Des-tyrosine1-gamma-endorphin.
    Geffard M, Gaffori O, Chauveau J, Muyard JP, Le Moal M.
    Neurosci Lett; 1981 Dec 23; 27(3):329-34. PubMed ID: 7329637
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
    Oelssner W, Peinhardt G, Büge A.
    Pharmazie; 1985 May 23; 40(5):341-2. PubMed ID: 2863832
    [Abstract] [Full Text] [Related]

  • 11. In vivo stereospecific [3H]spiperone binding in rat brain: characteristics, regional distribution, kinetics and pharmacological properties.
    Barone D, Luzzani F, Assandri A, Galliani G, Mennini T, Garattini S.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):63-74. PubMed ID: 4054217
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
    Battaglia G, Titeler M.
    Eur J Pharmacol; 1982 Jul 16; 81(3):493-8. PubMed ID: 6126376
    [Abstract] [Full Text] [Related]

  • 14. Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs.
    Laduron PM, Janssen PF, Leysen JE.
    Biochem Pharmacol; 1978 Feb 01; 27(3):317-21. PubMed ID: 23127
    [No Abstract] [Full Text] [Related]

  • 15. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC, Carino MA, Horita A.
    Proc West Pharmacol Soc; 1981 Feb 01; 24():5-6. PubMed ID: 6114496
    [No Abstract] [Full Text] [Related]

  • 16. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
    Hartley EJ, Spuhler K, Prasad KN, Seeman P.
    Brain Res; 1980 May 26; 190(2):574-7. PubMed ID: 6154511
    [No Abstract] [Full Text] [Related]

  • 17. Des-tyr-gamma-endorphin (DT gamma E) and pineal levels of melatonin and arginine vasopressin (AVP).
    King MG, Geffard MR, Chavreau J, Gaffori O, Le Moal M, Muyard JP.
    Eur J Pharmacol; 1981 Dec 03; 76(2-3):271-4. PubMed ID: 6120844
    [Abstract] [Full Text] [Related]

  • 18. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 19. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 02; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.